Company Overview - The company, established in 2001 and listed in 2011, has total assets of 8.023 billion RMB as of mid-2025 [2] - It is a key supplier in the automotive thermal management and lightweight system components sector [2][3] Future Capacity Plans - The company is advancing several projects, including: - Annual production of 2 million sets of high-strength aluminum system components for new energy vehicles - Annual production of 12 million lightweight high-performance aluminum profile components for automobiles - Annual production of 14,000 tons of high-efficiency, corrosion-resistant aluminum tubes for home air conditioning - A project for lightweight high-performance aluminum alloy quality enhancement - Annual production of 100,000 tons of high-end aluminum-based materials for green electricity [4] Overseas Acquisitions - On July 29, 2025, the company approved the acquisition of 100% equity in Alunited France SAS and Alunited Denmark A/S for €1.533 million, with an additional €1.467 million for operational capital [5] Shanghai Branch Establishment - The company established a Shanghai branch to enhance competitiveness in automotive, aerospace, robotics, and automation sectors, completing registration in November 2025 [6] Thermal Management Products - Key products include: - Aluminum materials for automotive cabin thermal management systems, such as air conditioning liquid cooling pipes and flow control valve materials - Aluminum materials for automotive power system thermal management, including condenser liquid cooling pipes and battery cooling pipes [7][8] Aerospace Product Development - The company specializes in high-end aluminum alloys for aerospace applications, leveraging experience from projects like the Shenzhou spacecraft and maintaining compliance with quality management standards [9] Production and Pricing Models - The company employs a "sales-driven production" model and a pricing strategy based on aluminum ingot prices plus processing fees, considering various cost factors [10] Future Development Outlook - The company anticipates growth opportunities driven by global sustainable development policies, industrial upgrades, and the dual circulation development pattern, particularly in automotive thermal management and lightweight technologies [11][12]

Company Overview - Yisheng Co., established in 1989, is the largest ancestor meat chicken breeding enterprise in China and Asia, holding a 1/3 market share of the domestic imported breeding chicken market [1] - The company has been the top in ancestor meat chicken breeding for 20 consecutive years, with the highest sales of commercial chicken seedlings in the country [1] - The company is expanding its breeding pig business, with sales expected to reach approximately 30,000 pigs in 2024 and 98,400 pigs in 2025 [1] Performance Metrics - In 2025, Yisheng Co. introduced 266,000 sets of ancestor white feather meat chickens, accounting for 43% of the national introduction volume, which is a historical high [2] - The company sold over 10 million parent chicken seedlings and over 640 million commercial chicken seedlings in 2025, with an expected annual profit of 150 to 190 million yuan [2][3] Future Outlook - For 2026, the company anticipates an increase in parent chicken seedlings supply compared to 2025, with expected sales of over 600 million commercial chicken seedlings and 150,000 pigs [3][6] - The market for parent white feather meat chicken seedlings is expected to remain strong due to increased demand and limited supply from external sources [4] Price Trends - The price of parent chicken seedlings has been rising since September 2025 due to supply shortages caused by avian influenza outbreaks [4] - The price of commercial chicken seedlings is expected to improve in 2026, supported by anticipated increases in pork prices [4] Production Capacity - The company's production capacity for parent chicken seedlings is directly linked to the import volume of ancestor chickens, with plans to increase the parent chicken stock to 10 million sets and commercial chicken seedlings to 1 billion in the next four years [6] - A new breeding facility in Shanxi is expected to add 100 million commercial chicken seedlings to the production capacity [6] Cost Management - The company aims to reduce costs in 2026 through improved internal management and production efficiency, assuming stable prices for raw materials [7]

Group 1: Support for Local Industries - The bank focuses on supporting Qingdao's characteristic industries, such as marine economy and biomedicine, by identifying financing needs along the industrial chain and promoting steady growth in loan scales for major local industries [2] - The bank is expanding the application scenarios for sustainable development-linked loans and enhancing its carbon accounting platform to support the district's dual carbon goals [2] - Specific products like "Marine High-tech Loan" and "Port Supply Chain Finance" are being launched to support the marine industry [2] Group 2: Asset Quality Outlook - The bank anticipates a continued stable improvement in asset quality, with a decreasing non-performing loan (NPL) ratio [2] - Factors contributing to the decline in NPL ratio include restructuring the credit organization and business processes, which has led to better quality in newly issued loans [2] - Proactive risk assessment and increased efforts in managing existing risk clients have helped mitigate the occurrence of new NPLs [2]

Group 1: Industry Overview - The company is optimistic about the space computing industry, which involves deploying powerful computing capabilities in space, such as installing high-performance computing units on satellites to process vast amounts of data locally [2][3] - The global demand for computing power is experiencing exponential growth, driven by advancements in artificial intelligence, big data, and cloud computing [2][3] - Training an advanced AI model consumes electricity equivalent to the annual usage of thousands of households, highlighting the significant energy demands of large data centers [2][3] Group 2: Investment and Strategic Moves - In June 2025, the company invested 110 million RMB in Beijing Orbit Chuangguang Technology Co., Ltd., which focuses on deploying computing satellites in the Earth's dawn-dusk orbit to create space data centers [3][4] - Following the investment, the company's stake in Orbit Chuangguang increased from 19.30% to 28.68% after a capital increase of approximately 74.98 million RMB [6] Group 3: Technological Developments - Orbit Chuangguang's technology aligns with global trends in space computing, utilizing 24/7 solar power and advanced cooling technologies to address energy supply and heat dissipation challenges [4] - Recent advancements include the successful launch of the Starcloud-1 satellite by Starcloud, which conducted the first data center-level GPU operations in space [5] Group 4: Future Prospects and Challenges - The first experimental satellite "Chuangguang-1" has been developed but is yet to be launched due to various factors affecting launch schedules [7] - The company anticipates steady operational performance in 2025, with its specialty anti-counterfeiting paper and printing businesses being the main revenue contributors [8]

Group 1: Marketing Strategies - The Pharmaceutical Business Group focuses on becoming the "first brand" in pain management, leveraging the efficacy of Yunnan Baiyao products in this field [2] - Significant growth in aerosol and plaster products, with a comprehensive marketing strategy integrating various channels and scenarios [2][3] - Online sales increased by over 20%, with a total of 48.45 million visitors and 3.54 million consumers generated through e-commerce platforms, resulting in a GMV of 254 million yuan [3] Group 2: Dividend Distribution - For the 2024 fiscal year, the company will distribute a cash dividend of 11.85 yuan per 10 shares, totaling approximately 2.16 billion yuan, which is 90.09% of the net profit attributable to shareholders [4] - The total cash dividend for 2024, including special dividends, amounts to 23.98 yuan per 10 shares, with a total of 4.28 billion yuan [4][5] - In the first half of 2025, a cash dividend of 10.19 yuan per 10 shares will be distributed, totaling 1.82 billion yuan, representing 50.05% of the net profit for that period [5] Group 3: Future Product Development - The Health Products Business Group aims to be a leader in high-quality health products, focusing on oral care and expanding the product ecosystem [6] - Continuous enhancement of the oral product line and development of new products to strengthen market position [6] Group 4: R&D Planning - The company emphasizes innovation-driven development, focusing on both traditional Chinese medicine and innovative pharmaceuticals [7] - Ongoing projects include 16 major traditional Chinese medicine varieties and 37 development projects, with a focus on innovative drug development [8] - Short-term projects aim to enhance existing products, while long-term projects focus on innovative drug development aligned with social needs and technological advancements [8]

Group 1: Meeting Overview - The investor meeting was held on January 23, 2026, at the company's headquarters [1] - Participants included representatives from Guotai Junan and Zhonghui Life Insurance [1] - The meeting was categorized as a telephone conference [1] Group 2: Company Representatives - The meeting was hosted by the Board Secretary, Qian Yinghui [1] - Investor relations management included Zhang Yu and Yang Kexin [1] Group 3: Main Discussion Points - The primary focus was to understand the company's production and operational status [1]

Group 1: Company Overview - Yunnan Baiyao Group Co., Ltd. is engaged in the production and operation of medicinal products [1] - The investor relations activity was conducted via a telephone conference on January 23, 2026 [1] Group 2: Participants - Participants included representatives from Guotai Junan and Agricultural Bank of China [1] - Company representatives included securities affairs representative Li Mengjue and investor relations managers Zhang Yu and Yang Kexin [1] Group 3: Meeting Objectives - The main objective of the meeting was to understand the company's production and operational status [1]

Group 1: AI Empowerment and Digital Transformation - The company is implementing its digital development plan (2022-2026) by leveraging data and AI technologies across key segments of the supply chain, enhancing operational efficiency and business innovation [2] - The self-developed "Marketing Business Operation Platform" has been piloted in the pharmaceutical business group, improving order processing and cost accounting, leading to a 30% reduction in manual workload and saving 60,000 paper documents annually [3] - The "One Product, One Code Traceability Platform" has been developed for traditional Chinese medicine, providing digital identity for authentic medicinal materials [2] Group 2: Supply Chain and Operational Efficiency - The company has achieved 100% automation in settlement processes, reducing the cycle from 30 days to real-time [3] - The establishment of 90 standard processes and 60 management indicators supports business decision-making effectively [3] - The "Smart Cloud Medicine" platform and "One Product, One Chain" model have created a closed-loop system covering all aspects from resource management to payment, significantly improving supply chain collaboration and management [3] Group 3: Research and Development Progress - The tumor organ library and molecular marker research projects have yielded results published in Cancer Cell and Chinese Clinical Oncology journals [4] - The INR101 diagnostic nuclear medicine project has entered phase III clinical trials, with 32 research centers established and 60 subjects enrolled [5] - The INR102 therapeutic nuclear medicine project has received a clinical trial notification, with phase I trials initiated and 12 patients enrolled [6] Group 4: Dividend Distribution - For the 2024 fiscal year, the company will distribute a cash dividend of 11.85 CNY per 10 shares, totaling 2,164,310,537.44 CNY, which represents 90.09% of the net profit attributable to shareholders [7] - The total cash dividend for 2024, including a special dividend, amounts to 23.98 CNY per 10 shares, with a total of 4,278,661,722.00 CNY distributed [7] - In the first half of 2025, a cash dividend of 10.19 CNY per 10 shares will be distributed, totaling 1.818 billion CNY, representing 50.05% of the net profit for that period [7] Group 5: Online Sales Performance - The pharmaceutical business group has seen over a 20% increase in O2O sales in the first half of 2025, aided by online content marketing [8] - The company generated 2.54 billion CNY in GMV from e-commerce platforms, attracting 4.845 million visitors and converting 3.54 million consumers [9] - Yunnan Baiyao toothpaste holds the number one market share in the domestic channel for 2025, while the brand ranked first in Tmall for anti-hair loss shampoo during the "618" shopping festival [9]

Group 1: Company Growth Plans - The company aims to increase customer penetration in the domestic market and develop new clients while enhancing import substitution [2] - Plans to leverage existing overseas clients' reputation and the benefits of being publicly listed to expand into international markets, including traditional markets in Europe and the US, as well as emerging markets in BRICS countries, Southeast Asia, and Africa [2] Group 2: Industry Demand Trends - The demand for all-steel giant tires is closely linked to the mining industry's growth, with tire consumption costs accounting for approximately 24% of operational expenses in large open-pit mines [3] - Global active large open-pit mines total 1,615, with around 63,900 giant mining trucks, indicating a robust market for all-steel giant tires [3] - By 2027, the global production of all-steel giant tires is expected to reach 358,000 units [3] Group 3: Product Pricing and Lifespan - Average prices for all-steel giant tires from January to June 2025 are: - 49-inch: CNY 51,300 per unit - 51-inch: CNY 87,000 per unit - 57-inch: CNY 182,800 per unit - 63-inch: CNY 347,000 per unit [6] - The lifespan of all-steel giant tires varies significantly based on factors such as mineral type, climate, road conditions, and load [5] Group 4: Industry Barriers - High technical barriers exist due to the demanding nature of all-steel giant tire production, requiring extensive practical feedback and long development cycles [7] - Market barriers arise from mining companies' focus on safety and efficiency, making it difficult for new entrants to gain acceptance [7] - The industry is capital-intensive, with high expectations for supplier reliability and production scale [7] Group 5: Future Outlook and Market Dynamics - The company is optimistic about maintaining a healthy gross margin despite increasing competition and market capacity, attributing this to high technical barriers and a focus on replacing international brands [9] - The replacement market for giant mining tires is significantly larger than the original equipment market, as tire selection is primarily based on mining conditions and owner preferences [10] - The company employs a direct sales model, engaging directly with clients, including well-known domestic and international mining companies [10]

Group 1: Business Overview and Product Applications - The company focuses on providing advanced system solutions and lifecycle services in the energy and power sectors, with products including compressors and heat exchangers, covering a temperature range of -271°C to 200°C [3] - Products are widely used in various industries such as food processing, cold chain logistics, industrial refrigeration, commercial air conditioning, and energy recovery systems [3] - The company has developed innovative technologies for nuclear power applications, including cooling systems and heat recovery solutions, supporting multiple nuclear power stations in China [6][7] Group 2: Data Center and Cooling Systems - The company’s subsidiary, Dunham-Bush, provides cooling equipment for data centers, including variable frequency centrifugal chillers and integrated natural cooling systems, with successful projects in both domestic and international markets [4] - The proportion of centrifugal chillers, especially magnetic levitation types, is increasing in the IDC market, while the proportion of screw chillers is decreasing [6] - The company has established a global after-sales service system supported by overseas manufacturing bases [6] Group 3: Heat Recovery and Energy Management - The company’s heat management segment focuses on industrial heat pumps and has been recognized as a national-level specialized "little giant" enterprise, with 96 patents and 33 software copyrights [8] - The company’s technologies for waste heat recovery and high-temperature heat pumps are aligned with national carbon neutrality policies, providing long-term demand certainty [10] - The company’s absorption heat exchangers and other technologies have received multiple national awards and recognitions for their energy-saving capabilities [9] Group 4: Aerospace and Fusion Energy Applications - The company produces liquefaction units for aerospace fuels, including hydrogen and methane, and has developed a helium gas compressor for superconducting magnet cooling systems used in controlled nuclear fusion [11][12] - The helium gas compressor is recognized as a significant technological equipment project by the National Energy Administration, supporting major scientific research projects [11] Group 5: Financial Projections and Market Demand - The joint venture with Yantai Modern Ice Wheel Heavy Industry is projected to generate revenues of over 700 million in 2024 and approximately 1 billion in 2025, driven by strong market demand [7]